CONTENTS

The angiologist and carotid disease in 2009. M. CAZAUBON, G.A. PELOUZE....................................... 5
When technological advances are pushing the science or consciousness. M. CAZAUBON, G.A. PELOUZE .................................. 7


Roundtable stroke


Carotid stenosis: beyond the light!.J.-L. BERTRAND, G.-A. PELOUZE, J.-M. BÉNÉJEAN........................ 13
Search for thrombophilia in the etiological of arterial ischemic stroke in young patients: the experience of the Centre Hospitalier de Perpignan. G. RUNAVOT, D. SABLOT, M. JOLY, B. FADAT, A. DUTRAY..................23
Fibrinolysis in cerebral ischemia.. SABLOT, Z. KASSEM, G. RUNAVOT, C. NEGRE...................................... 39
What's new in the secondary prevention of cerebral ischemia?. C. LUCAS ........................... 47
Carotid stenting in 2009. B. Beyssen .................................................53
Carotid Doppler ultrasound to identify pre-clinical vascular disease and assess the risk
Cardiovascular. Translated by M. CAZAUBON .............................................57
List of procedures and services long-term illness: stroke.
HAS: Update June 2009 .......................................................... 66


Cardiovascular Prevention


Role of aspirin and statins in primary prevention. M.-C. AUMONT..................................... 83
Should be used statins (rosuvastatin) for primary prevention of cardiovascular disease and venous thromboembolism?. C. BIRON-ANDRÉANI............................................. 85


Erectile Dysfunction


Cardiovascular disease, erectile dysfunction and myeloperoxidase. . ROUMEGUÈRE, P. V. ANTWERPEN,
K. ZOUAOUI BOUDJELTIA, M. VANHAEVERBEEK, E. WESPES .............................. 88


Clinical Cases


Association of femoral pseudoaneurysm and contralateral femoral aneurysm.M. FITOUSSI................... 93


Analysis of articles and books


Travel and Risk for Venous Thromboembolism.  F. CHLEIR .......................... 97
The 10 key points on the heparin-induced thrombocytopenia (HIT). Mr. CAZAUBON ..................... 98
Program JIFA 2010 ..............................................9
Membership form to the SFA ............................................... 84
Advertisers list .......................................................................... 95
Subscriptions ....................................................................... 96
EPP information ..................................................................................... 99
Conference proceedings ............................................................. 100
Announcements of conferences and events ...........................................105
Press Release - XARELTA ® ................................................ 108
Instructions to Authors ..................................................... Cover. 3

CONTENTS

EDITORIAL....................................................................................................... 5
PLENARY OF THE SFA: OUR STRENGTHS AND CHALLENGES IN OUR IMAGE
VASCULAR...........................................................................................8
OUR CHALLENGES IN PATHOLOGY RENAL ARTERY......................................................... 14
PREVENTION OF RISK IN THE PAD.......................................... 17
OUR CHALLENGES IN THE LOWER limb ischemia: THE END OF
FOGARTY BALLOON?..................................................................................................................22
INVITED .............................................................................................................27
SPOTLIGHT ON THROMBOSIS ............................................. ..................................................... 33
SFP SESSION: CHALLENGES IN OUR VEIN THROMBOSIS: THE LIMITATIONS
THERAPEUTIC INDICATIONS ......................................................................................................  35
SFP SESSION: OUR ASSETS AND OUR CHALLENGES FOR THE TREATMENT OF VARICOSE VEINS
KEY LOWER LIMBS IN 2009 .................................................................. 37
FRANCO SHOW - ITALIAN VENOUS DISEASE
TREATMENT OF VARICOSE VEINS: THE END GAME ANGIO / PHLEBO SURGEON? ................ 45
MEDICAL COMPRESSION: EXPERIMENTAL EVIDENCE OF IMPROVEMENT
OF COMPLIANCE / SYMPOSIUM SIGVARIS ................................................................................. 55
JOINT MEETING AND SFA SFMS:
ERECTILE DYSFUNCTION / OUR ASSETS AND A CHALLENGE: PREVENTION! ................................ 60
MEETING OF VASCULAR NETWORK FRENCH SCIENCE
IMPLEMENTATION OF RECOMMENDATIONS ANGIOLOGY COUNTRIES
FRANCOPHONE...........................................................................  63
SUMMARY AND DISCUSSIONS OF MEETINGS ..................................................... 66
Advertisers list ........................................................................................................41
New website of the SFA ...............................................................................................59
Ad Congress 2010  ......................................................................................77
Call for Papers for 2010 JIFA  .....................................  78
Junior Price 2010....................................................................  79
Introducing LIVE........................................................................ 80
Subscriptions..................................................................................................  82
Advice to authors ...............................................................................  83
European Venous Forum................................................................................... 84

CONTENTS

The new challenge of Angiology. M. CAZAUBON...................................................5
Advocacy for telangiectasia: their explorations, their salaries, and their financial impact. J.C. SCIALOM .................................................. 7

Arterial disease

Place assays of apolipoproteins A1 and B in the lipid profile. Technology Assessment Report - HAS -
September 2008....................................................17
Inadequate platelet response to clopidogrel and peripheral vascular disease. O. MOREL ............. 30

Thrombo embolic

Discontinuation of anticoagulant therapy after a first spontaneous venous thrombotic events, how
identify patients?  C. BIRON-ANDREANI ................................................ 39
Epidemiology of venous thromboembolism in AIDS in Sub Saharan Africa. P. ZABSONRE, A. K. SAMADOULOUGOU, J. Y. TOGUYENI, J. P. KABORE..........................................42

Phlebology

Superficial venous thrombosis of the lower limbs: the limitations of therapeutic indications. J.-L. GILLET.............................................47
Some new considerations on venous valvuloplasty: an International Debate on line. G. B. AGUS ............................ 52
Some new considerations on the venous valvuloplasty: an international debate on Internet

Clinical Cases

Arterial thrombosis and nephrotic syndrome. D. SÈNE, F. KOSKAS, P. CACOUB................... 62
Venous thromboembolic disease complicated with nephrotic syndrome: report of a case.
M. C. MBOUP, Ad. KANE, M.B. NDIAYE, M. DIAO, I.B. DIOP, M. SARR, A. KANE, S.A. BA .................... 65

Namely

Reform of the first year of medical studies ............................................ 69
Focus on the EPP and the FMC............................................71

Call for Papers for 2010 JIFA

Pre-program JIFA 2010  ............................ 11
Free Communications  .................................... 14
Prix ​​Louis Gerson / Price Junior of the SFA  .................................... 15
Membership form to the SFA ........................................  9
Press Release - TAREG®............................................................73
Announcement of Conference ..............................................75, 76
Advertisers list...........................................77
Subscriptions.......................................78
Instructions to Authors....................................80